Jefferies Financial Set to Report Earnings Soon; Top Analysts Update Predictions Before Earnings Call
Earnings Report: Jefferies Financial Group Inc. is set to release its third-quarter earnings on September 29, with analysts predicting earnings of 80 cents per share and revenue of $1.92 billion, an increase from the previous year.
Strategic Alliance Expansion: On September 19, Jefferies Financial announced an expansion of its global strategic alliance with Sumitomo Mitsui Financial Group, enhancing their collaboration that began in 2021.
Trade with 70% Backtested Accuracy
Analyst Views on SMFG
About SMFG
About the author
Buffett's Legacy Continues as Abel Takes Over Berkshire Hathaway
- Portfolio Overview: Berkshire Hathaway's stock portfolio is valued at $267 billion, with approximately one-quarter in financial stocks, representing 40% of the total value, highlighting the company's strong positioning in the financial sector.
- Ally Financial's Strategic Shift: Ally Financial exited the mortgage origination business last year to focus on auto loans, which improved its credit quality and net interest margin; analysts project a target price of $52.50, indicating a potential 24% return by 2026 as interest rates decline.
- Jefferies Financial's Market Opportunities: As a pure-play investment bank, Jefferies Financial benefits from the active M&A market, with investment banking revenue rising 12% last year; despite a 19% stock price drop due to losses related to First Brands' bankruptcy, analysts remain bullish with a target price of $77, suggesting a 26% upside.
- Buffett's Investment Recommendations: Ally Financial and Jefferies Financial are highlighted as Buffett's quality financial stocks, making them key targets for investors in February to capitalize on the recovery opportunities in the market.
U.S. Stocks Face Second Week of Losses, Nasdaq Dips 0.1%
- Market Performance: The S&P 500 index barely rose 0.03% this week but fell 0.4% overall, indicating investors' insufficient capacity to digest geopolitical news, leaving market sentiment unsettled.
- Natural Gas Surge: Natural gas futures spiked 75% over five trading days due to Winter Storm Fern, reflecting the impact of extreme weather on energy demand and potentially raising profit expectations for related companies.
- Dollar Depreciation Trend: Over the past five days, the EUR/USD rose nearly 2%, while the dollar fell over 2.7% against the Swiss franc, indicating a shift in investor sentiment away from the dollar, which may affect future forex market dynamics.
- Fed Policy Expectations: The market widely anticipates that the Federal Reserve will maintain interest rates in the 3.5%-3.75% range at next week's meeting, with investors closely watching Trump's nomination for the new Fed chair, which could influence future monetary policy direction.
Financial Stocks Dip Pre-Bell as State Street Faces Pressure
- Market Sentiment Weakens: Financial stocks are leaning lower ahead of Monday's opening bell, indicating investor concerns about market outlook, which could impact short-term capital flows and investment decisions.
- State Street Under Pressure: As a key player in the financial sector, State Street's poor performance may exert downward pressure on its stock price, potentially affecting the overall stability of the financial markets.
- Investor Vigilance: Market participants are closely monitoring upcoming economic data and policy developments, which could further influence the performance of financial stocks and investor confidence.
- Increased Volatility: The decline in financial stocks may lead to heightened market volatility, prompting investors to navigate potential market risks cautiously, especially in an environment of increasing uncertainty.
Daily Upgrade Report for Validea's John Neff Strategy - December 12, 2025
Validea's Low PE Investor Model: Today's upgrades for Validea's Low PE Investor model, based on John Neff's strategy, highlight several stocks with improved ratings, indicating potential investment interest based on their fundamentals and valuations.
Cheesecake Factory Inc (CAKE): The Cheesecake Factory's rating increased from 62% to 81%, reflecting strong fundamentals and valuation, with a focus on its extensive restaurant operations and diverse menu offerings.
Sumitomo Mitsui Financial Group Inc (SMFG): This large-cap value stock's rating rose from 60% to 79%, showcasing its financial services across various segments, including wholesale and retail banking.
Voya Financial Inc (VOYA): Voya Financial's rating surged from 60% to 98%, indicating strong interest due to its comprehensive workplace benefits and savings solutions, catering to both individual and institutional clients.
Most Active Stocks in Pre-Market on December 2, 2025: INTC, EB, TSLL, TQQQ, NVDA, IREN, IBIT, SMFG, NIO, T, INVH, PFE
NASDAQ 100 Pre-Market Performance: The NASDAQ 100 Pre-Market Indicator is up 119 points to 25,461.85, with a total pre-market volume of 97,034,402 shares traded.
Active Stocks Overview: Intel Corporation (INTC) and Eventbrite, Inc. (EB) are among the most active stocks, with INTC trading at $40.55 (+0.54) and EB at $4.44 (+1.96), both exceeding their target prices significantly.
Notable Stock Movements: ProShares UltraPro QQQ (TQQQ) and NVIDIA Corporation (NVDA) show strong performance, with TQQQ up 212.4% from its 52-week low and NVDA receiving positive earnings forecast revisions.
Mixed Results for Other Stocks: Stocks like IREN Limited (IREN) and NIO Inc. (NIO) are underperforming, trading below their target prices, while AT&T Inc. (T) and Pfizer, Inc. (PFE) remain in the "buy range" according to analysts.
3 Japanese Stocks Poised for Over 20% Growth Worth Investing In Now
Japanese Stocks as Investment: Japanese companies have become a popular investment choice globally, with Warren Buffett's Berkshire Hathaway increasing its investments in Japanese stocks to over $30 billion, including a stake in Mitsubishi above 10%.
Mizuho Financial (MFG): Mizuho, a major financial institution in Japan, has a price target of $39.22 set by DBS analyst Lim Rui Wen, indicating a potential upside of 500.20%.
Sumitomo Mitsui (SMFG): Sumitomo, a holding company for Sumitomo Mitsui Banking Corporation, has a price target of $32.79 from another DBS analyst, suggesting a 93.93% upside.
Takeda Pharmaceutical Company (TAK): Takeda, Japan's leading pharmaceutical firm, has a reaffirmed price target of $18 by TD Cowen analyst Michael Nedelcovych, indicating a 27.75% upside potential.
Buffett's Legacy Continues as Abel Takes Over Berkshire Hathaway
- Portfolio Overview: Berkshire Hathaway's stock portfolio is valued at $267 billion, with approximately one-quarter in financial stocks, representing 40% of the total value, highlighting the company's strong positioning in the financial sector.
- Ally Financial's Strategic Shift: Ally Financial exited the mortgage origination business last year to focus on auto loans, which improved its credit quality and net interest margin; analysts project a target price of $52.50, indicating a potential 24% return by 2026 as interest rates decline.
- Jefferies Financial's Market Opportunities: As a pure-play investment bank, Jefferies Financial benefits from the active M&A market, with investment banking revenue rising 12% last year; despite a 19% stock price drop due to losses related to First Brands' bankruptcy, analysts remain bullish with a target price of $77, suggesting a 26% upside.
- Buffett's Investment Recommendations: Ally Financial and Jefferies Financial are highlighted as Buffett's quality financial stocks, making them key targets for investors in February to capitalize on the recovery opportunities in the market.
U.S. Stocks Face Second Week of Losses, Nasdaq Dips 0.1%
- Market Performance: The S&P 500 index barely rose 0.03% this week but fell 0.4% overall, indicating investors' insufficient capacity to digest geopolitical news, leaving market sentiment unsettled.
- Natural Gas Surge: Natural gas futures spiked 75% over five trading days due to Winter Storm Fern, reflecting the impact of extreme weather on energy demand and potentially raising profit expectations for related companies.
- Dollar Depreciation Trend: Over the past five days, the EUR/USD rose nearly 2%, while the dollar fell over 2.7% against the Swiss franc, indicating a shift in investor sentiment away from the dollar, which may affect future forex market dynamics.
- Fed Policy Expectations: The market widely anticipates that the Federal Reserve will maintain interest rates in the 3.5%-3.75% range at next week's meeting, with investors closely watching Trump's nomination for the new Fed chair, which could influence future monetary policy direction.
Financial Stocks Dip Pre-Bell as State Street Faces Pressure
- Market Sentiment Weakens: Financial stocks are leaning lower ahead of Monday's opening bell, indicating investor concerns about market outlook, which could impact short-term capital flows and investment decisions.
- State Street Under Pressure: As a key player in the financial sector, State Street's poor performance may exert downward pressure on its stock price, potentially affecting the overall stability of the financial markets.
- Investor Vigilance: Market participants are closely monitoring upcoming economic data and policy developments, which could further influence the performance of financial stocks and investor confidence.
- Increased Volatility: The decline in financial stocks may lead to heightened market volatility, prompting investors to navigate potential market risks cautiously, especially in an environment of increasing uncertainty.
Daily Upgrade Report for Validea's John Neff Strategy - December 12, 2025
Validea's Low PE Investor Model: Today's upgrades for Validea's Low PE Investor model, based on John Neff's strategy, highlight several stocks with improved ratings, indicating potential investment interest based on their fundamentals and valuations.
Cheesecake Factory Inc (CAKE): The Cheesecake Factory's rating increased from 62% to 81%, reflecting strong fundamentals and valuation, with a focus on its extensive restaurant operations and diverse menu offerings.
Sumitomo Mitsui Financial Group Inc (SMFG): This large-cap value stock's rating rose from 60% to 79%, showcasing its financial services across various segments, including wholesale and retail banking.
Voya Financial Inc (VOYA): Voya Financial's rating surged from 60% to 98%, indicating strong interest due to its comprehensive workplace benefits and savings solutions, catering to both individual and institutional clients.
Most Active Stocks in Pre-Market on December 2, 2025: INTC, EB, TSLL, TQQQ, NVDA, IREN, IBIT, SMFG, NIO, T, INVH, PFE
NASDAQ 100 Pre-Market Performance: The NASDAQ 100 Pre-Market Indicator is up 119 points to 25,461.85, with a total pre-market volume of 97,034,402 shares traded.
Active Stocks Overview: Intel Corporation (INTC) and Eventbrite, Inc. (EB) are among the most active stocks, with INTC trading at $40.55 (+0.54) and EB at $4.44 (+1.96), both exceeding their target prices significantly.
Notable Stock Movements: ProShares UltraPro QQQ (TQQQ) and NVIDIA Corporation (NVDA) show strong performance, with TQQQ up 212.4% from its 52-week low and NVDA receiving positive earnings forecast revisions.
Mixed Results for Other Stocks: Stocks like IREN Limited (IREN) and NIO Inc. (NIO) are underperforming, trading below their target prices, while AT&T Inc. (T) and Pfizer, Inc. (PFE) remain in the "buy range" according to analysts.
3 Japanese Stocks Poised for Over 20% Growth Worth Investing In Now
Japanese Stocks as Investment: Japanese companies have become a popular investment choice globally, with Warren Buffett's Berkshire Hathaway increasing its investments in Japanese stocks to over $30 billion, including a stake in Mitsubishi above 10%.
Mizuho Financial (MFG): Mizuho, a major financial institution in Japan, has a price target of $39.22 set by DBS analyst Lim Rui Wen, indicating a potential upside of 500.20%.
Sumitomo Mitsui (SMFG): Sumitomo, a holding company for Sumitomo Mitsui Banking Corporation, has a price target of $32.79 from another DBS analyst, suggesting a 93.93% upside.
Takeda Pharmaceutical Company (TAK): Takeda, Japan's leading pharmaceutical firm, has a reaffirmed price target of $18 by TD Cowen analyst Michael Nedelcovych, indicating a 27.75% upside potential.
